SMA is an autosomal recessive genetic disease in which an individual inherits two deleted or mutated SMN1 genes—one from each parent:4

Molecular genetic testing is an important tool in the diagnosis of SMA6,7

Although newborn screening is not yet standard practice, time to diagnosis is critical. Based on the natural history of the disease, earlier diagnosis leading to earlier intervention may help improve outcomes for individuals with SMA.10


1. Lefebvre S, et al. Cell. 1995;80:155–65. 2. Kolb SJ, Kissel JT. Arch Neurol. 2011;68:979–84. 3. Lunn MR, Wang CH. Lancet. 2008;371:2120–33. 4. National Organization for Rare Diseases. Spinal muscular atrophy. Available at: Accessed November 2017. 5. Prior TW. Obstet Gynecol Clin N Am. 2010;37:23–36. 6. Wang CH, et al; J Child Neurol. 2007;22:1027–49. 7. D’Amico A, et al. Orphanet J Rare Dis. 2011;6:71. 8. Butchbach ME. Front Mol Biosci. 2016;3:7. 9. Pyatt RE, et al. Clin Chem. 2007;53:1879-85. 10. Rothwell E, et al. Am J Med Genet A. 2013;161A:679–86. 11. Lin CS, et al. Pediatr Neurol. 2015;53:293–300. 12. Qian Y, et al. BMC Neurol. 2015;15:217. doi:10.1186/s12883-015-0473-3. 13. Lawton SL, et al. Eur J Hum Genet. 2015;23:575–80. 14. Leyenaar J, et al. Paediatr Child Health. 2005;10:397–400. 15. Peredo DE, Hannibal MC. Pediatr Rev. 2009;30:e66–e76. 16. Bodensteiner JB. Semin Pediatr Neurol. 2008;15:10–20. 17. North KN. Semin Pediatr Neurol. 2011;18:216–20. 18. Van Toorn R. CME: Your SA Journal of CPD. 2004;22:449–55. 19. McDonald CM. Phys Med Rehabil Clin N Am. 2012:23:495–563. 20. Darras BT, et al. Neuromuscular Disorders of Infancy, Childhood, and Adolescence: A Clinician’s Approach. 2nd ed. London, UK: Elsevier; 2015.